Navigation Links
King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion
Date:11/24/2008

various pending legal proceedings; expectations regarding King's financial condition and liquidity as well as future cash flows and earnings; expectations regarding the ability to liquidate King's holdings of auction rate securities and the temporary nature of the unrealized losses recorded in connection with these securities. Forward-looking statements involve risks and uncertainties. For further information regarding these and other risks related to King's business, investors should consult King's most recent Annual Report on Form 10-K for the year ended December 31, 2007 and King's quarterly reports on Form 10-Q and other documents filed by King with the Securities and Exchange Commission ("SEC").

Alpharma's Forward-Looking Statement

The statements contained herein that are not historical facts are considered forward-looking statements. Such forward-looking statements are based on the beliefs of our management as well as assumptions made by and information currently available to them and involve certain risks and uncertainties and other factors that could cause actual results to differ materially from those in the forward-looking statements. Alpharma has no obligation to update such forward-looking statements. Information on other important potential risks and uncertainties not discussed herein may be found in Alpharma's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2007 and its Form 10-Q for the quarter ended September 30, 2008. All forward-looking statements are qualified by these cautionary statements and are made only as of the date they are made.

Important Additional Information about the Tender Offer

This press release is provided for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell Alpharma Class A Common Stock. The solicitation and offer to buy Alpharma's Class A Common St
'/>"/>

SOURCE King Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the Presidents Council on Physical Fitness and Sports, to Board of Directors
2. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
3. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
4. Keryx Biopharmaceuticals Receives Nasdaq Notification
5. Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain
6. FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
7. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
8. MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
9. MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
10. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
11. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... ... ... With a new charity program in the Chico, CA area, Gary Short & ... of deaths and injuries occurring from police pursuits, and announced that they will be ... police to find better and safer ways to conduct pursuits. To support this wonderful ...
(Date:7/27/2015)... ... July 27, 2015 , ... At Champagne Smiles, they ... that tooth loss can incur a lot of stress, pain, discomfort and embarrassment, which ... The All-On-4™ treatment reaps the benefits of implants with the cost savings of ...
(Date:7/27/2015)... ... , ... In a creative effort to provide clear information about the process ... at Dove Tree in Lubbock has shared a new infographic to illustrate the process. ... Both the nationally recognized collegiate program and traditional adult program at The Ranch at ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... SupplyLogic, a ... executive blog on its newly redesigned company Website. In the blog, Founder and CEO ... of a popular comedian: "Comedian George Wallace always asks: ‘Why is it the closer ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... ... serving communities in and around Dallas, Texas, is announcing a joint charity effort ... support and employment resources for American veterans who are returning from overseas. , ...
Breaking Medicine News(10 mins):Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 2Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 2Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 4Health News:The Ranch At Dove Tree Infographic Enlightens Process Of Recovery 2Health News:The Ranch At Dove Tree Infographic Enlightens Process Of Recovery 3Health News:SupplyLogic Releases First Executive Blog on Supply Chain Management Issues 2Health News:The Tedesco Agency of North Dallas and Non-Profit IAVA Announce Joint Charity Effort to Support American Veterans 2
... Nearly one in 10 obstetricians in a new study ... emotional toll of stillbirths and infant deaths. , ... survey by researchers at the University of Michigan Health ... toll on them personally. , "Our survey reveals that ...
... to Launch a Program in Support of the Heightened National Response ... ... Platinum selling,singer/songwriter/producer Lyfe Jennings kicked off his Baby I,m a Star,summer concert ... with the tour, Lyfe is partnering with Music World,Entertainment to launch a ...
... to develop rheumatoid arthritis in adulthood as their average ... the Annals of the Rheumatic Diseases . , ... which argues that certain conditions and diseases in adult ... Diabetes, coronary heart disease, and high blood pressure, for ...
... (p. 26). In this second annual,double issue, Newsweek poses ... whether politicians should pander, whether having,children makes you happier ... global warming. Readers can also test their Global IQ ... issue. Try these:, 1. How many presidents achieved ...
... to regulate emotions can determine both neurological and physiological ... University and Rutgers University neuroscientists has discovered. The findings, ... Nature Neuroscience , shed light on how the ... Previous research has demonstrated these strategies can alter responses ...
... a replacement organ that never arrives , , SUNDAY, June ... clinging to life this very second, and their only ... The science of organ transplantation has improved by leaps ... died in 2005, waiting for a replacement organ that ...
Cached Medicine News:Health News:Stillbirths, infant deaths lead to anxiety, guilt and stress among obstetricians 2Health News:Lyfe Jennings Launches Summer Tour and HIV/AIDS Awareness Initiative 2Health News:NEWSWEEK: Media Lead Sheet - July 7-14, 2008 Double Issue (On Newsstands Monday, June 30) 2Health News:NEWSWEEK: Media Lead Sheet - July 7-14, 2008 Double Issue (On Newsstands Monday, June 30) 3Health News:NEWSWEEK: Media Lead Sheet - July 7-14, 2008 Double Issue (On Newsstands Monday, June 30) 4Health News:NEWSWEEK: Media Lead Sheet - July 7-14, 2008 Double Issue (On Newsstands Monday, June 30) 5Health News:NYU, Rutgers study shows how using mental strategies can alter the brain's reward circuitry 2Health News:Organ Donation: An Advancing Science Hindered by Supply Shortages 2Health News:Organ Donation: An Advancing Science Hindered by Supply Shortages 3
(Date:7/27/2015)... , July 27, 2015 Bloomage BioTechnology ... announces a strategic cooperation with the South Korean BioTech ... a joint venture Medybloom to develop and promote Type ... China . Medytox, the Botulinum ... and is also the fourth company in the world ...
(Date:7/27/2015)... , July 27, 2015   DocResponse ... technology application in a peer-reviewed study , ... triage: audit study", published in the July issue ... study by Harvard Medical School researchers determined that ... DocResponse listing the correct diagnosis first in standardized ...
(Date:7/27/2015)... , Belgium , July 27, ... VNRX), a life sciences company focused on developing blood-based ... and other conditions, today announced that it has engaged ... organization, Global Specimen Solutions, Inc. (GSS), to support initial ... cancer tests. Under the agreement, GSS ...
Breaking Medicine Technology:Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China 2Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China 3Harvard Study Finds DocResponse Most Accurate Medical Symptom Checker/Diagnostics Application 2Harvard Study Finds DocResponse Most Accurate Medical Symptom Checker/Diagnostics Application 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 2VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 4VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 5VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 6VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 7
... CVM ) announces that its CEL-1000 immunomodulator was ... against the recombinant hepatitis B,virus protein more quickly than ... was seen within 14 days, most pronounced with a ... up to a 40% increase in antibody,signal at day ...
... Ontario, Sept. 19 ArtJen Complexus Holdings,Corp. (http://www.fbcx.com ... trial with obese type 2 diabetics and an animal ... studied by a major US,west-coast university medical center. The ... fiber that binds dietary fat will involve,overweight but not ...
Cached Medicine Technology:CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein 2CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein 3ArtJen Announces Major Clinical Trial of Its Patented Weight Loss Product FBCx 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: